Mayne Pharma GroupMYX 
$3.132.89%24h
2.89%24h
Global rank15467
Market cap$257.41M
Change 7d-
YTD Performance-24.72%
SP500 benchmarkUnderperform
P/E0
P/S2.09
Revenue$123.39M
Earnings$79.26M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Mayne Pharma Group (MYX)
Mayne Pharma Group has an EPS of $-3.2. In 2021, the company made an earnings per share (EPS) of $-2.652. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for MYX
-
Value:-
EPS history for Mayne Pharma Group from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2022 | -$3.20 | 20.66% |
| 2021 | -$2.65 | 118.45% |
| 2020 | -$1.21 | - |
View the highest EPS stocks
